Jonathon Unwin
Stock Analyst at Barclays
(0.15)
# 4,457
Out of 4,581 analysts
55
Total ratings
17.9%
Success rate
-22.1%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Sell | kr 26.00 → kr 29.00 | kr 35.10 | -17.38% | 13 | Jul 23, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Rated: Buy | 172p → 160p | 111p | +43.76% | 7 | Jul 14, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | €28.00 | €28.74 | -2.57% | 10 | Jul 7, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Maintained: Buy | CHF 386.00 | CHF 390.60 | -1.18% | 6 | Jun 25, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | €16.00 | €21.20 | -24.53% | 12 | May 13, 2026 | |
| ETR: GXI Gerresheimer AG | Downgraded: Sell | €23.00 → €19.00 | €26.54 | -28.41% | 7 | Apr 28, 2026 |
Vimian Group AB (publ)
Jul 23, 2026
Maintained: Sell
Price Target: kr 26.00 → kr 29.00
Current: kr 35.10
Upside: -17.38%
Oxford Nanopore Technologies plc
Jul 14, 2026
Rated: Buy
Price Target: 172p → 160p
Current: 111p
Upside: +43.76%
Carl Zeiss Meditec AG
Jul 7, 2026
Maintained: Hold
Price Target: €28.00
Current: €28.74
Upside: -2.57%
Ypsomed Holding AG
Jun 25, 2026
Maintained: Buy
Price Target: CHF 386.00
Current: CHF 390.60
Upside: -1.18%
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: €16.00
Current: €21.20
Upside: -24.53%
Gerresheimer AG
Apr 28, 2026
Downgraded: Sell
Price Target: €23.00 → €19.00
Current: €26.54
Upside: -28.41%